<DOC>
	<DOC>NCT00415935</DOC>
	<brief_summary>A comparison of outcome in children with JIA who are in remission on MTX, when MTX is then stopped for either 6 or 12 months</brief_summary>
	<brief_title>PRINTO (the Paediatric Rheumatology International Trials Organisation)</brief_title>
	<detailed_description />
	<mesh_term>Arthritis, Juvenile</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Any child with JIA who has gone into remission using methotrexate</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>December 2006</verification_date>
</DOC>